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An assessment of the quality of Oral and Maxillofacial surgery clinical practice guidelines is 
lacking. The aim of this investigation was to assess the quality of guidelines using the  
RIGHT (Reporting Items for practice Guidelines in HealThcare) checklist. The primary outcome 
was to assess the score (quality) of guidelines based on the RIGHT checklist and to identify 
predictors (region, type, single/or multi-center and speciality/non-speciality) influencing the 
quality score. In this review, following a search of electronic databases and national society 
websites, a total of 25 guidelines were independently assessed by two assessors against the 
22-item RIGHT checklist. Inter-assessor reliability was assessed.  Deficiencies in the reporting 
of items relating to Limitations, Funding, Declaration and Management of Interests, Health Care 
Questions and Quality Assurance were evident. The median overall score for the guidelines was 
28 (range14-66). Guidelines produced by multi-centres (β = 57.15, 95% CI: -26.62, 87.68, 
p=0.001) and non-speciality societies (β = 20, 95% CI: -0.03-40.03, p=0.05) tended to have 
higher quality scores.  Overall, the quality of clinical practice guidelines used in Oral and 
Maxillofacial surgery were deemed sub-optimal. If clinical practice guidelines are to be in 




Clinical Practice Guidelines are systematically developed recommendations formulated in 
order to aid decision-making among healthcare professionals with regards to appropriate care 
provision in certain clinical scenarios1. There is evidence to suggest that well-designed, evidence-
based and explicit guidelines may lead to significant improvements in outcomes of care when 
implemented in various domains of medical practice2. However, there are concerns regarding the 
quality of published guidelines over the past decades, with the majority not adhering to basic 
methodological standards in developing recommendations for practice3,4.  The advocacy of such 
guidelines may promote harmful, ineffective and inefficient practice within healthcare5. 
Formatting... please waitSimilarly, there are concerns of bias relating to guidelines published by 
influential professional/specialist societies with increasing output of non-systematic expert 
opinions presented by specialists or society members as a means of publicity or increasing 
academic visibility6. This may potentially bring into question the reliability and validity of clinical 
recommendations put forward by such groups. 
 
Therefore, it is of paramount importance to appraise the quality of clinical guidance and improve 
standards prior to their publication. There is evidence to affirm that reporting standards improves 
the quality of research7-9. Multiple instruments have been proposed as a means of assessing 
standards, notably such as the internationally validated AGREE (Appraisal of Guidelines, 
Research and Evaluation) instrument10. Recently, the RIGHT (Reporting Items for practice 
Guidelines in HealThcare) checklist formulated by an international working group developed in 
2013, offers a novel approach in assessing the methodological quality of guidelines for users, 
authors and evaluators11. This comprises of a 22-item comprehensive checklist that were deemed 
essential for good reporting of practice guidelines by the group. 
 
 
Such quality assessments have previously been conducted across the board in various medical 
and dental subspecialties4,12,13, however a review of clinical guidelines within Oral and 
Maxillofacial Surgery is lacking. The purpose of this study was to assess the quality of clinical 
practice guidelines published within the field of Oral and Maxillofacial surgery as reflected by the 
score achieved when assessed using the RIGHT checklist. The investigators hypothesize that 
there is no difference in the scores (quality) between different guidelines. Specifically, we aimed 
to establish whether factors such as region, type of guidelines, single/or multi-center authors and 
speciality/or non-speciality produced guidelines can act as predictors for guideline quality.  
 
Materials and Methods 
Study design and sample  
A cross-sectional assessment of Oral and Maxillofacial surgery clinical practice guidelines was 
undertaken.  An electronic literature search was conducted across multiple databases in order to 
identify guidelines relevant to Oral Surgery or Oral and Maxillofacial Surgery. Conference 
abstracts, position statements and guidelines not published in English were excluded. A 
MEDLINE (Ovid) search, as well as searches on TRIP (Turning Research Into Practice), SIGN 
(Scottish Intercollegiate Guidance Network), SDCEP (Scottish Dental Clinical Effectiveness 
Programme) and NICE (National Institute For Health and Clinical Excellence) databases were 
conducted and results were restricted to the years 2000-2019. Further searching was carried out 
on relevant national and international organization websites such as AAOMS (American 
Association of Oral and Maxillofacial Surgeons), RCSEng (The Royal College of Surgeons of 
England) and BAOS (British Association of Oral Surgeons). All articles were first screened 
independently to identify relevant guidelines. Full-text articles were retrieved, and a secondary 
screening was then carried out with two assessors independent of each other (MA and AB) to 
identify suitable guidelines. A discussion was held subsequently, and any disagreements were 
 
resolved with a third assessor (JS) in order to establish the final list of guidelines to be included 
in the study. (Figure 1) 
 
Data variables and data collection 
The RIGHT checklist (Appendix I) and score of each guideline was used as a means of 
reporting the quality and completeness of each of the guidelines identified. It comprises of 22 
items with some subcategories making a total of 34 points on the checklist. These encompass a 
series of seven domains including: Basic Information (items 1 to 4), Background (items 5 to 9), 
Evidence (items 10 to 12), Recommendations (items 13 to 15), Review and Quality Assurance 
(items 16 and 17), Funding and Declaration and Management of Interests (items 18 and 19) and 
Other Information (items 20 to 22). Each guideline was independently assessed by two assessors, 
determining whether each item of the RIGHT checklist was fully reported (2 points), partially 
reported (1 point) or not reported (no points). The maximum score that could be achieved would 
be 68 representing complete adherence to the RIGHT checklist and a high level of quality. The 
“RIGHT Explanation and Elaboration: guidance for reporting practice guidelines” supplemental 
document was referred to directly by two assessors (MA and AB) when each guideline was 
assessed.  A pilot assessment of 5 guidelines was carried out to assess inter-assessor reliability 
and confirm calibration of the assessors. Any discrepancies in the assessment amongst 
assessors were discussed with a third assessor (JS) until consensus was achieved. The following 
data variables were also recorded: year and continent of publication (region), number of authors, 
single or multi-centre publication i.e. contribution by authors at same or multiple institutions and 







 The level of agreement between assessors was evaluated using the Kappa statistic. A 
non-normal distribution of the data was assessed and confirmed from graphical methods. 
Descriptive statistics for individual reporting items of the RIGHT checklist were calculated. The 
quality score of each guideline was also determined. Median linear regression modelling was 
implemented with univariate analysis to identify characteristics associated with the median 
percentage total score; multivariate modelling was used to determine the adjusted effect on the 
median percentage total score. Significant predictors identified during the univariable analysis 
were entered individually in the multivariable model. The final model was derived by comparing 
candidate models using the likelihood ratio test. A two-tailed p-value of 0.05 was considered 
statistically significant. All analyses were performed using Stata statistical software version 15 

















The majority of checklist items demonstrated an acceptable level of inter-examiner reliability. 
(mean: 85.1%, SD: 19.0%, range 40-100%) (Table 1).  
 
Search results 
A total of 25 guidelines were identified across the databases (Figure 1) and (Table 2) 
Guideline demographics 
Of the 25 guidelines, 56% of guidelines evaluated were from the UK (n=14) with the remaining 
from the USA (n=11) (Table 3). The majority of guidelines were of single-centre origin (56%, n=14) 
and were specialty based (56%, n=14). Most guidelines identified were published after 2010, with 
over half (n=13) being from after 2016. When considering the evidence base of the guidelines, a 
larger proportion were seen to be of mixed-type (80%, n=20), encompassing formal evidence, 
consensus and expert opinion. 44% (n=11) of guidelines produced were by the American 
Association of Oral and Maxillofacial Surgeons (AAOMS), 28% (n=7) by the Royal College of 
Surgeons of England (RCSEng), 12% (n=3) by the Scottish Dental Clinical Effectiveness 
Programme (SDCEP) and the remainder by other institutions. 
Quality of Reporting 
Poorly reported areas included items 22 (Limitations of Guideline), 10 (Healthcare questions), 18 
(Funding source and role of funder), 19 (Declaration and Management of Interests) and 17 
(Quality assurance). Well-reported items included 20 (Access), 7 (Target population), 1 
(Title/Subtitle), 13 (Recommendations) and 6 (Aim of the guideline and specific objectives). Item 
13a (Provide clear, actionable recommendations) was reported on in all guidelines, but was 
deemed incomplete or partially reported by the assessors in 40% of cases. Similarly, 11b 
 
(Referencing of systematic reviews and selection process) was reported on 84% of guidelines but 
was mostly partially reported (48%) (Table 4) (Figure 2). The overall median quality score for the 
total sample was 28 (range 14-66) (Table 2). 
Linear Regression Analysis 
Univariable analysis showed significant differences in the quality of guidelines produced by single 
and multi-centre (β =51.43, 95% CI: 30.32,72.54, p<0.01). Subsequent multi-variable analysis 
confirmed guidelines produced by multi-centres were of higher quality compared to guidelines 
produced by a single centre (β =57.15, 95% CI: -26.62, 87.68, p=0.001). In the univariable linear 
regression analysis, guidelines produced by non-speciality organisations achieved higher quality 
scores compared to speciality based guidelines (β =20, 95% CI: -0.03, 40.03, p<0.05) (Table 5).  
 
Discussion 
The aim of this study was to assess the quality of clinical practice guidelines published 
within the field of Oral and Maxillofacial surgery using the RIGHT checklist. The investigators’ 
hypothesis that there is no difference between quality scores of guidelines was disproven as 
discussed below. The study results indicate the overall median score across the guidelines (n=25) 
was 28 (range 14-66). Whether factors such as region, type of guidelines, single/or multi-center 
authors and speciality/or non-speciality produced guidelines played a role in influencing quality 
score was also investigated. Guideline predictors that were of significance included multi-center 
produced guidelines which showed higher quality scores when compared to guidelines produced 
by a single centre. This is positively affirmed by Mubeen et al. 13 who also showed that guidelines 
produced within dentistry by multi-centers were of higher quality when assessed using the 
AGREE II checklist. The involvement of multiple centres may serve to reduce bias by promoting 
selection of stakeholders participating in guideline development from a wide range of 
backgrounds and interests. Furthermore, it was noted that non-specialty-based guidelines were 
 
of higher quality than specialty-based when assessed using the RIGHT checklist. This has been 
eluded to in the literature 6 attributing this to the notion that non-specialty-based guidelines are 
more impartial and provide better quality guidance.  
Items such as Access, Basic Information, Background and Aims and Objectives were all 
well reported with the worst reported items being Limitations, Funding, Declaration and 
Management of Interests, Health Care Questions and Quality Assurance.  When looking generally 
at healthcare guidelines across Europe, previous studies have reported deficiencies in similar 
areas 14,15.  Quality Assurance (item 17) was incorporated as a criterion in the RIGHT checklist, 
unlike the AGREE II instrument, with our data showing only 24% of guidelines reporting on this. 
Although quality assurance measures for guidelines exist, they are not always universally 
implemented as reported in this study findings, with a tendency for government programs to 
employ these more than professional societies 16. As such, it has been suggested that in order 
for guidelines to maintain high quality standards they should be produced within structured and 
coordinated programs by leading guideline agencies, or if they are to be produced by specialist 
societies, quality criteria from guideline agencies should be adopted17. This was of note in this 
study, with guidelines produced through structured and coordinated programs reporting on a 
greater number of items on the RIGHT checklist. Limitations (item 22), Funding (item 18) and 
Declaration and Management of Interests (item 19) were poorly reported, which raises concerns 
about bias in the current recommendations. Although it seems that overall guideline reporting 
quality has improved over the past decades, type and involvement of stakeholders seem to be 
especially poorly reported in practice guidelines developed by specialist societies18. It was also 
notable that processes assessing the certainty of the body of evidence (item 12) were deemed 
fully reported in only 28% of guidelines evaluated. This is of particular significance with current 
emphasis being on evidence-based medicine and practice based on scientific principles. 
Guidelines based on formal evidence seemed to perform better based on reporting of items on 
the checklist, however, univariable analysis showed this not be of significance.  
 
 Item 10 (Healthcare Questions) which relates to the PICO framework (Population, 
Intervention, Comparison and Outcome) was fully reported in 4% of guidelines. This is a 
framework used to facilitate the formulation of clinical questions to aid research in guideline 
development. The RIGHT checklist is unique in its inclusion of PICO as an indicator of quality of 
evidence-based recommendations, associating this with more focused and targeted research. 
This lack of PICO reporting endures to be a common theme within the literature with one study 
attributing this to PICO not adequately representing questions relating to prognosis, diagnosis 
and aetiology20. The regression analysis found some variation in scores of guidelines published 
in Europe or North America, however, this was not significant. No guidelines from other continents 
were identified in our search, and there seems to be a trend in that most guidelines are published 
in high-income countries. This may be attributed to less funding and support from government 
agencies for guideline development and decreased likelihood of guidelines being published in 
indexed journals14, therefore our results may not be representative universally.  
 It is stressed by the authors of the RIGHT checklist that it is has not been designed as a 
means of deriving an overall score to assess guideline quality, but rather it is an adjunct to other 
appraisal tools such as the AGREE II instrument to assess whether items not taken into account 
by other tools are reported11. The RIGHT checklist is the only tool that incorporates quality of 
evidence as part of guideline evaluation, with many other instruments designed lacking in this 
aspect21. Therefore, we believe the use of an overall percentage score evaluating which items 
were reported on was justified as a means of assessing how well existing guidelines conform to 
this checklist. Furthermore, as no previous assessment using has been undertaken, it was 
decided by the investigators to give each item equal weighting.  Our literature search only yielded 
25 guidelines and over half of these were written after 2016. This suggests that there is an evident 
shortage of clinical practice guidelines in oral and maxillofacial surgery, behind other domains of 
medicine, such as oncology, which has a longer history of guidance development with seemingly 
superior quality in comparison to other subject areas19. Although it is beyond the scope of this 
 
study, it should be noted that guideline validity was not assessed as part of the RIGHT checklist, 
which has been suggested to be evaluated no later than 3 years after guideline publication. 22,23 
Considering the range of publication dates of guidelines within Oral and Maxillofacial surgery, this 
may be an area of interest for future studies. Moreover, guidelines analysed in this study were 
from the US and UK only. Assessment of non-english guidelines would require translation of both 
the guideline and RIGHT checklist which may result in errors and misrepresentation of the quality 
scores. Kappa agreement scores showed generally a high level of inter-assessor reliability giving 
the study findings high external reliability. Accessibility to guidelines possibly reduced our sample 
size, and this combined with the factors previously mentioned may have led to biases within our 
data resulting from the over/under estimation of quality. Oral and Maxillofacial Surgery however, 
remains to be a field where only a handful of guidelines exist, thus the authors stress the need for 
further high quality guideline development to aid clinicians. Future studies may also wish to 
investigate and compare the quality of Oral and Maxillofacial guidelines to other medical or 
surgical specialties as well as the current validity of these guidelines. 
 In conclusion, the findings of this study have highlighted based on this sample of oral and 
maxillofacial guidelines the overall quality is low when assessed using the RIGHT checklist. The 
reporting of quality assurance processes, sources of funding, conflicts of interest and other 
potential sources of bias, as well as appraisal of the research and evidence base in the guideline 
development process requires improvement. Guidelines produced by non-speciality 
organisations and those produced by multiple centres tend to be of a higher quality. In the 
development of future guidelines, the use of non-speciality societies, multi-centres and the RIGHT 
checklist to ensure standards is advocated. If clinical practice guidelines are to be in making 
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Management Considerations for 
Pediatric Oral Surgery and Oral 
Pathology 
American Academy of 
Pediatric Dentistry 
Single 26 
Management of Unerupted Maxillary 
Incisors 
Royal College of Surgeons of 
England 
Multi 28 
Management of the Palatally Ectopic 
Maxillary Canine 
Royal College of Surgeons of 
England 
Multi 35 
Temporomandibular Disorders (TMDs): 
an update and management guidance 
for primary care from the UK Specialist 
Interest Group in Orofacial Pain and 
TMDs (USOT) 
Royal College of Surgeons of 
England 
Multi 41 
The Oral Management of Oncology 
Patients Requiring Radiotherapy, 
Chemotherapy and/or Bone Marrow 
Transplantation 
Royal College of Surgeons of 
England 
Single 31 
Guidelines for Selecting Appropriate 
Patients to Receive Treatment with 
Dental Implants: Priorities for the NHS 
Royal College of Surgeons of 
England 
Multi 28 
Guidelines for Surgical Endodontics Royal College of Surgeons of 
England 
Multi 18 
Management of primary cutaneous 




Oral health management of patients at 
risk of medication-related osteonecrosis 
of the jaw 
National Institute for Health 
and Care Excellence 
Multi 59 
The Management of Patients With 
Third Molar Teeth 
National Institute for Health 
and Care Excellence 
Single 29 
Guideline on acquired 
temporomandibular disorders in infants, 
children, and adolescents 
National Institute for Health 
and Care Excellence 
Single 30 
Total prosthetic replacement of the 
temporomandibular joint  
National Institute for Health 
and Care Excellence 
Single 28 
Guidance on the Extraction of Wisdom 
Teeth  
National Institute for Health 
and Care Excellence 
Single 26 
Clinical Practice Guideline: Evaluation of 
The Neck Mass in Adults. 
American Academy of 
Otolaryngology - Head and 
Neck Surgery Foundation 
Multi 66 
Conscious Sedation in Dentistry Scottish Dental Clinical 
Effectiveness Programme 
Multi 57 
Evidence-based clinical practice 
guideline for the evaluation of potentially 
malignant disorders in the oral cavity: a 
report of the American Dental 
Association. 
American Dental Association Multi 59 
Oral and Craniofacial Implant Surgery American Association of Oral 
and Maxillofacial Surgeons 
Single 14 
Temporomandibular Joint Surgery American Association of Oral 




















Surgical Correction of Maxillofacial 
deformities 
American Association of Oral 
and Maxillofacial Surgeons 
Single 16 
Diagnosis and Management of 
Pathological Conditions 
American Association of Oral 
and Maxillofacial Surgeons 
Single 19 
Trauma Surgery American Association of Oral 
and Maxillofacial Surgeons 
Single 18 
Facial Cosmetic Surgery American Association of Oral 
and Maxillofacial Surgeons 
Single 19 
Guidelines to the Evaluation of 
Impairment of the Oral and Maxillofacial 
Region 
American Association of Oral 
and Maxillofacial Surgeons 
Single 21 
Management of Dental Patients Taking 
Anticoagulants or Antiplatelet Drugs 
Scottish Dental Clinical 
Effectiveness Programme 
Multi 58 
Conscious sedation British Dental Association Single 18 
 
 
Characteristic  Category n % 
Publication year 1997 1 4 
  2000 1 4 
  2011 1 4 
  2012 3 12 
  2013 1 4 
  2014 2 8 
  2015 3 12 
  2016 2 8 
  2017 10 40 
  2018 1 4 
      
Country UK 14 56 
  USA 11 44 
      
Number of centers Single center 14 56 
  Multi center 11 44 
      
Source of guideline Specialty based 14 56 
  Non- Specialty based 11 44 
      
Type of guideline Expert opinion 1 4 
  Consensus based 1 4 
  Formal evidence 3 12 


























1a) Identify the report as a guideline, that is, with “guideline(s)” or “recommendation(s)” in the 
title 
12 0 88 
1b) Describe the year of publication of the guideline 12 0 88 
1c) Describe the focus of the guideline, such as screening, diagnosis, treatment, management, 
prevention or others 
44 0 56 
2) Provide a summary of the recommendations contained in the guideline 40 4 56 
3) Define new or key terms, and provide a list of abbreviations and acronyms if applicable 48 0 52 
4) Identify at least one corresponding developer or author who can be contacted about the 
guideline 
44 0 56 
5) Describe the basic epidemiology of the problem, such as the prevalence/incidence, morbidity, 
mortality, and burden (including financial) resulting from the problem. 
48 8 44 
6) Describe the aim(s) of the guideline and specific objectives, such as improvements in health 
indicators (e.g., mortality and disease prevalence), quality of life, or cost savings 
28 4 68 
7a) Describe the primary population(s) that is addressed by the recommendation(s) in the 
guideline. 
4 4 92 
7b) Describe any subgroups that are given special consideration in the guideline. 16 4 80 
8a) Describe the intended primary users of the guideline (such as primary care providers, 
clinical specialists, public health practitioners, program managers, and policy-makers) and 
other potential users of the guideline 
24 36 40 
8b) Describe the setting(s) for which the guideline is intended, such as primary care, low- and 
middle-income countries, or in-patient facilities 
56 8 36 
9a) Describe how all contributors to the guideline development were selected and their roles and 
responsibilities (e.g., steering group, guideline panel, external reviewer, systematic review team, 
and methodologists) 
72 12 16 
9b) List all individuals involved in developing the guideline, including their title, role(s) and 
institutional affiliation(s) 
44 8 48 
10a) State the key questions that were the basis for the recommendations in PICO (population, 
intervention, comparator, and outcome) or other format as appropriate 
96 0 4 
10b) Indicate how the outcomes were selected and sorted 64 4 32 
11a) Indicate whether the guideline is based on new systematic reviews 60 0 40 
11b) If the guideline developers used existing systematic reviews, reference these and describe 
how those reviews were identified and assessed (provide the search strategies and the selection 
criteria, and describe how the risk of bias was evaluated) and whether they were updated 
16 48 36 
12) Describe the approach used to assess the certainty of the body of evidence 60 12 28 
13a) Provide clear, precise, and actionable recommendations 0 40 60 
13b) Present separate recommendations for important subgroups if the evidence suggests that 
there are important differences in factors influencing recommendations, particularly the balance 
of benefits and harms across subgroups 
20 4 76 
14a) Describe whether values and preferences of the target population(s) were considered in the 
formulation of each recommendation. If yes, describe the approaches and methods used to elicit 
or identify these values and preferences. If values and preferences were not considered, provide 
an explanation 
48 20 32 
14b) Describe whether cost and resource implications were considered in the formulation of 
recommendations. If yes, describe the specific approaches and methods used (such as cost-
effectiveness analysis) and summarize the results. If resource issues were not considered, provide 
an explanation 
72 8 20 
14c) Describe other factors taken into consideration when formulating the recommendations, 
such as equity, feasibility and acceptability 
80 4 16 
15) Describe the processes and approaches used by the guideline development group to make 
decisions, particularly the formulation of recommendations (such as how consensus was defined 
and achieved and whether voting was used) 
68 8 24 
16) Indicate whether the draft guideline underwent independent review and, if so, how this was 
executed and the comments considered and addressed. 
68 12 20 
17) Indicate whether the guideline was subjected to a quality assurance process. If yes, describe 
the process 
76 0 24 
18a) Describe the specific sources of funding for all stages of guideline development 76 0 24 
18b) Describe the role of funder(s) in the different stages of guideline development and in the 
dissemination and implementation of the recommendations 
84 0 16 
19a) Describe what types of conflicts (financial and non-financial) were relevant to guideline 
development 
80 4 16 
19b) Describe how conflicts of interest were evaluated and managed and how users of the 
guideline can access the declarations 
76 0 24 
20) Describe where the guideline, its appendices, and other related documents can be accessed 4 0 96 
21) Describe the gaps in the evidence and/or provide suggestions for future research 36 12 52 
22) Describe any limitations in the guideline development process (such as the development 
groups were not multidisciplinary or patients‟ values and preferences were not sought), and 
indicate how these limitations might have affected the validity of the recommendations 

































































































Quality of Reporting of RIGHT Checklist Items















Predictor Variables Univariable Multivariable 




    
  
    
  N. America -17.15 -50.95, 16.65 0.31       






    
  




-4.29 -112.92,104.3 0.94 




20 -68.69, 108.69 0.64 
      






    
Baseline 
reference 
    



















Legends to figures and tables 
Figure 1 Flow diagram of full-text article identification  
Figure 2 Graph representing percentage distribution of scoring for each item in the RIGHT 
checklist for clinical guidelines (n=25). 
Table 1 Inter-assessor reliability (Kappa agreement) scores per item of RIGHT statement 
reporting tool 
Table 2 List of guidelines identified and individual RIGHT checklist scores (n=25) 
Table 3 Characteristics of clinical practice guidelines included (n=25) 
Table 4 Percentage distribution of scoring for each item in the 22-item RIGHT Checklist for 
clinical practice guidelines (n= 25) 
Table 5 Univariate and multivariate linear regression derived coefficients (β) and 95% confidence 
intervals (CI) for Median percentage total score as dependent variable for the 25 clinical practice 
guidelines. * p-value <0.05, ** p-value <0.01 
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